Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
National Institutes of Health
Want a reminder before this closes?
We'll email you 3 days before the deadline. One email, then we stop.
Free. Verify your email, then we send one reminder only.
- Posted
- Dec 17, 2025
- Closes
- Nov 5, 2027 (in 374 days)
Similar opportunities open now
- Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses Nov 2027
- High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Mar 2027
- High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Mar 2027Up to $1.5M
- Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Jan 2028
- Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Nov 2028Up to $400K
Classification and identifiers
- Solicitation number
- PAS-25-073
- Assistance listing (CFDA)
- 93.847
Amount
Amount not listed here. Check the official program.
Who can apply
Nonprofits, State government agencies, and Small businesses can all apply here. Check the eligibility details below to see if your organization fits.
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
About this opportunity
This Notice of Funding Opportunity (NOFO) seeks to stimulate HIV/AIDS research within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) that align with the HIV/AIDS research priorities outlined by the NIH Office of AIDS Research (OAR). These priorities were most recently described in NOT-OD-20-018 UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.